secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001193125-23-256153
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex faces Nasdaq delisting over bid price; appeals, reports equity compliance
--------------------------------------------------------------------------------

- Received Nasdaq delisting determination on Oct 10, 2023 for failing minimum bid price compliance (bid below $1 for 30 days).
- Company intends to appeal; appeal stays suspension pending Hearings Panel decision, so stock remains listed for now.
- Believes regained compliance with Nasdaq equity standard (min $2.5M equity) after recent capital raises totaling ~$10.96M gross proceeds.
- Recent raises: public offering of 9.6M shares for ~$9.6M (Oct 3), plus two private placements ($582k and $650k) and ATM sales (~$123k).
- Caution that future compliance with bid price or equity standards is uncertain; no assurance of continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523256153/0001193125-23-256153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312523256153/d512775d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-256153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer